Patents Assigned to Amicrobe, Inc.
  • Compositions and uses of antimicrobial materials with tissue-compatible properties
    Patent number: 12016898
    Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.
    Type: Grant
    Filed: March 1, 2022
    Date of Patent: June 25, 2024
    Assignee: Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Jarrod A. Hanson
  • Compositions and uses of antimicrobial materials with tissue-compatible properties
    Patent number: 11298401
    Abstract: Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.
    Type: Grant
    Filed: August 18, 2016
    Date of Patent: April 12, 2022
    Assignee: Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Jarrod A. Hanson
  • Composition with high antimicrobial activity and low toxicity
    Patent number: 10448634
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: October 22, 2019
    Assignees: The Regents of the University of California, Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • Compositions and uses of materials with high antimicrobial activity and low toxicity
    Patent number: 9017730
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: April 28, 2015
    Assignees: The Regents of the University of California, Amicrobe, Inc.
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol
  • COMPOSITIONS AND USES OF MATERIALS WITH HIGH ANTIMICROBIAL ACTIVITY AND LOW TOXICITY
    Publication number: 20130267458
    Abstract: Improved synthetic copolypeptide antimicrobials contain cationic amino acid residues and may be based on a blocky sequence. These antimicrobials show low mammalian toxicity and may undergo directed self-assembly. The inventive synthetic copolypeptides are useful in treatment of wounds and other infections.
    Type: Application
    Filed: February 25, 2013
    Publication date: October 10, 2013
    Applicants: Amicrobe, Inc., The Regents of the University of California
    Inventors: Michael P. Bevilacqua, Diego Benitez, Timothy J. Deming, Jarrod A. Hanson, Lucas Koziol